Results 81 to 90 of about 51,514 (235)

Alopecia Areata [PDF]

, 2017
Alopecia areata is an organ-specific autoimmune disease targeting hair follicles. It causes nonscarring hair loss. The prevalence rate of the disease is approximately 1 in 1000 people worldwide.
Engin, Burhan, Tüzün, Yalçın, Çiğdem Oba, Muazzez   +2 more
core   +2 more sources

Metabolic and Vascular Inflammation in Alopecia Areata: Linking Uric Acid, Lipid Imbalance and ICAM‐1 Upregulation

Experimental Dermatology, Volume 34, Issue 12, December 2025.
ABSTRACT Alopecia areata (AA) is an inflammatory hair loss disorder caused by an immune‐mediated attack of the hair follicle (HF) bulb. Active disease is characterised by a peribulbar proinflammatory infiltrate, HF immune privilege collapse and premature catagen induction, yet the underlying drivers of AA remain poorly understood.
Madoc Dawson, Derek Pye, Rebecca Mahon, George Taylor, Asim Shahmalak, Bessam Farjo, Nilofer Farjo, Matthew Harries, Talveen S. Purba   +8 more
wiley   +1 more source

Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise

Australasian Journal of Dermatology, Volume 66, Issue 7, Page 404-412, November 2025.
ABSTRACT Background/Objectives Janus kinase inhibitors (JAKis) have been approved by the Therapeutic Goods Administration for severe alopecia areata (AA) in Australia. However, access is limited as JAKis are not currently subsidised on the Pharmaceutical Benefits Scheme for this indication. This study aimed to establish expert consensus on criteria for
Meryl Thomas, Madeline Hankins, Emadodin Darchini‐Maragheh, Laita Bokhari, Samantha Eisman, Leona Yip, Katherine York, Jane Li, Pooja Sharma, Daranporn Triwongwaranat, Vijaya Chitreddy, Ragini Ghiya, Daniella Kushnir‐Grinbaum, John Frewen, Shin Shen Yong, Deepani Rathnayake, William Cranwell, Dmitri Wall, Vanathy Varathan, Kiarash Khosrotehrani, David Orchard, Anthony Moussa, Meghana Paranjape, Rodney Sinclair   +23 more
wiley   +1 more source

Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement

Australasian Journal of Dermatology, Volume 66, Issue 7, Page e444-e460, November 2025.
ABSTRACT Over 5000 patients are newly diagnosed with Alopecia areata (AA) in Australia each year. AA severity varies from a single small patch to complete loss of scalp hair, body hair including eyelashes and eyebrows. Approximately 40% of affected individuals experience only a single patch and achieve spontaneous, complete and durable remission within
Daniella Kushnir‐Grinbaum, Laita Bokhari, John Frewen, Anthony Moussa, Daranporn Triwongwaranat, Ragini Ghiya, Flavia Rodrigues Dias, Shin Shen Yong, Bevin Bhoyrul, Zeyad Dabbagh, Ahmed Kazmi, Adam Daunton, Jane Li, Leona Yip, Vivian Lai, Katherine York, William Cranwell, Dmitri Wall, Samantha Eisman, Rodney Sinclair   +19 more
wiley   +1 more source

Alopecia universalis with twenty-nail dystrophy (trachyonychia)

Dermatology Online Journal, 2008
A 43-year-old man presented with long-standing trachyonychia of all 20 nails, which worsened after the onset of alopecia universalis 18 months ago. Trachyonychia can be associated with alopecia universalis although the treatment strategies of both conditions differ.
Jr, Peter Chien, Kovich, Olympia I
openaire   +4 more sources

Adipose Tissue‐Derived Exosomes in the Treatment of Lichen Planopilaris: A Case Report

Clinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT Adipose‐derived exosomes may offer a novel therapeutic approach for lichen planopilaris (LPP) unresponsive to standard treatments, with preliminary evidence suggesting potential benefits in symptom control and hair preservation.
Mohammad Ali Nilforoushzadeh, Ali Ezzatollahi Tanha, Soraya Talebi, Yekta Ghane, Niloufar Najar Nobari   +4 more
wiley   +1 more source

The concurrent association of inflammatory polymyositis and Crohn’s ileo-colitis in a Sri Lankan man: a case report of a rare association and literature review [PDF]

, 2014
BACKGROUND: Crohn’s disease is a relapsing, systemic inflammatory disease affecting the gastrointestinal tract with associated extraintestinal manifestations and immune disorders.
Champa Jayasundara, Nilesh Fenandopulle, Upul Liyanage, Vipula R Bataduwaarachchi   +3 more
core   +1 more source

The Use of Light‐Based Therapies in the Treatment of Alopecia

Journal of Cosmetic Dermatology, Volume 24, Issue 9, September 2025.
ABSTRACT Background Alopecia encompasses a group of conditions that can significantly impact quality of life, especially among women and younger individuals. While pharmaceutical therapies remain the cornerstone of treatment, laser and light‐based therapies, especially low‐level light therapy (LLLT), offer promising noninvasive alternatives.
Robert J. Vanaria, Aysham Chaudry, Mark S. Nestor   +2 more
wiley   +1 more source

Alopecia Areata and Systemic Lupus Erythematosus: Insights From a Nationwide Case–Control Study

International Journal of Dermatology, Volume 65, Issue 1, Page 152-153, January 2026.
Yonit Wohl, Annabel Maruani, Amir Bentov, Yarden Drutin, Jacob Mashiah   +4 more
wiley   +1 more source

SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 1, Page e5-e7, January 2026.
Ziad Reguiai, Leila Asfour, Delphine Staumont‐Sallé, Ángela Hermosa‐Gelbard, Andrea Sechi, Dalia Wajsbrot, Rahmat Ishowo‐Adejumo, Deborah Woodworth, Alexandre Lejeune   +8 more
wiley   +1 more source